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Transformation of Big Data for Health in the European Union 




Modern healthcare is increasingly dependent on good data, and effective information systems, for care delivery, 
and to develop and evaluate health policy. The context of big data differs in significant ways from traditional 
types of health data, while the use of big data for epidemiology and public health is becoming more common, the 
use of these tools for health service planning and health policy making lags behind. A large EU funded project 
(titled MIDAS) that focuses on merging, analysing and visualising data from heterogeneous sources to support 
health policy makers work in using and accessing health data across EU countries is underway. This paper briefly 
describes the key challenges that must be met to access, use and make sense of this big data in healthcare, focusing 
on legal, governance and ethical issues. Unless these issues are dealt with, the promise of Big Data for health, 
will never be fulfilled. 
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1.0 Introduction                                                                                                    
Digital epidemiology is motivated by the same objectives as traditional epidemiology, but focuses on 
electronic data sources that emerged with the advent of information technology (Hay et al., 2013).  
It draws on developments such as the online growth of sharing platforms, which constantly generate 
vast amounts of data containing health related information (Vayena et al., 2015). Utilizing available 
global real-time data accelerated disease outbreak detection is feasible. Reports of emerging outbreaks 
have been detected through digital surveillance channels in advance of official reports e.g. Ebola virus 
outbreak, West Africa (Anema et al., 2014), assessment of health behaviour and attitudes (Salathe & 
Khandelwal 2011) and pharmacovigilance (White et al., 2013). 
 
Big Data technology and services are expected to grow worldwide at a compound annual growth rate 
of 40% (Vessat, 2012). The European Commission adopted the communication on the data-driven 
economy, focusing on the digital economy, innovation and services as drivers for growth and jobs and 
called for EU action to provide the right framework conditions for a single market for Big Data and 
cloud computing (Com, 2014, 442). They are also bringing in a new general EU legal framework on 
the protection of personal data. The General Data Protection Regulation aims at eliminating 
fragmentation and providing consistency and coherence for the whole Union (Com, 2012, 11). This is 
critical for the wider reuse of personal data in Europe. 
 
The European Commission Directorate-general for Health and Consumers Protection (DG SANCO) 
are committed to capturing the potential of Big Data in public health policy and research to produce 
policy recommendations to member states according to the logic improvement of healthcare systems 
and in light of the Directive 2011/24/EU on Patients' Rights in Cross-Border Healthcare (Union, 
E.P.a.C.o.t.E., DIRECTIVE 2011/24/EU on the application of patients’ rights in cross-border 
healthcare, 2011). In this context, they have funded the MIDAS project, which seeks to develop tools 
for accessing analysing and interpreting heterogeneous data sources, oriented towards health policy 
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2.0 Big Data and Public Health                                                                                     
Big data cannot be readily grouped into clearly demarcated functional categories. Depending 
on how they are queried and combined with other datasets, a given dataset can traverse categories 
in unpredictable ways (Vayena et al., 2015). New data analytics constantly change the kinds of 
outcomes that become possible.  
 
They go beyond early identification, and detection of disease patterns to include predictions of the 
event’s trajectory or likelihood of recurrence (Thomas, 2014; Brockmann & Helbing, 2014). These 
possibilities render good data governance, which is essential for ethical use. The last two decades 
have seen an explosion in big data throughout the healthcare value chains, as well as the advent of 
new platforms, tools, and methodologies in storing, structuring, and analysing big data (Bernstein, 
2014).  
 
Numerous questions can be addressed with big data analytics. Clinical outcomes may be predicted 
and/or estimated based on vast amounts of historical data, such as length of stay; patients who will 
choose elective surgery; patients at risk of surgical complications; risk for sepsis, MRSA, C. difficile, 
or other hospital acquired illness (Manyika et al., 2011). 
 
Within public health applications included analysis of disease patterns and tracking disease outbreaks 
and transmission to improve surveillance and speed response (Raghupathi and Raghupathi, 2014).  
Faster development of more accurately targeted vaccines, e.g., choosing the annual influenza strains; 
and, turning large amounts of data into actionable information that can be used to identify needs, 
provide services, predict and prevent crises for the benefit of populations (Manyika et al., 2011). 
Optimisation of pharmaceutical outcomes utilising a variety of statistical techniques ranging from 
predictive modelling to machine learning, data mining is another area of rapid development. 
(Hernandez and Zhang, 2017). 
The MIDAS project, data analytics and operations research applications will inform practitioners and 
policy makers solving healthcare problems. Supporting the development of sustainable long-term 
solutions across disease management, service delivery, and health policies, in part by optimizing the 
performance of system elements and analysing interactions (Capan et al., 2017) 
   
3.0 Big Data Challenges 
The big data dynamic environment generates challenges that relate not only to the value of health 
systems, individual rights and other moral requirements (Vayena et al., 2015). The distinct features 
are the methods by which data are generated, collected and stored. The kind of information that is 
inferred by their analysis, and eventually how that information is translated into practice (Neff, 2013). 
Data analytics technology can derive value in ways that were previously impossible, the technical  
capabilities have reached a level of sophistication and pervasiveness that demands careful 
consideration and presents several challenges.  
 
3.1 Governance  
Public health surveillance and public health research are governed by national and international 
legislation and guidelines. Many of these norms were developed in response to technologies that have 
now been superseded (Fairchild & Bayer, 2004). Such mechanisms may not be appropriate or 
effective in addressing the new ethical challenge posed nor the questions that will be raised if big data 
is effectively integrated into standard public health systems. Health research utilizing social media 
data and other online datasets have already exerted pressure on existing research governance 
procedures (Vayena et al., 2012).  
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As the amount of health related data and global digital information grows, so does the number of 
actors accessing and using this information. Assurances must be given that personal data related to 
health will be used appropriately, in the context of the intended uses and according to relevant laws. 
There is public scepticism about “where my data goes”, “by whom it is used” and “for what purpose” 
in the fragmented and complex legal environment of the EU (EU Report, Use of Big Data in Public 
Health Policy Research, 2014).  
 
A strong governance model and adaptation of best practices of new technologies are essential for the 
deployment of big data for large-scale data production, coupled with interoperable data storage, data 
integration, and data analytics solutions (Meldolesi et al., 2016). Further, evaluation of data needs to 
be assessed and interpreted in a timely manner (Hood et al., 2014; Raghupathi et al., 2014) to improve 
the efficiency, effectiveness, prediction and prevention strategies of public health services and policy 
(Rumsfeld et al., 2016; Monteithet al., 2016).   
 
3.2 Confidentiality & Security  
An important condition for the access to patient related information is the protection of personal data. 
Data protection rules as transposed into national laws in Europe do not yet establish full-harmonized 
conditions for health data processing, although this will improve as the General Data Protection 
Regulation (GDPR) is adopted (Maldoff, 2016).  
 
Existing computational infrastructures can readily cope with the storage of big data, but the specific 
challenge for the EU is the lack of a suitable large-scale European infrastructure and methods of 
secure data distribution in a cross-border setting (Georgatos et al., 2013). 
 
It is crucial to ensure the infrastructures that exist and evolve are coordinated and sustainable.        
There are significant differences of culture and practice within and across Europe for data access and 
data, sharing polices (DLA Piper, 2016). Recently a code of practice on the secondary use of medical 
data in European research has been developed (Bahr et al., 2015) and deployed in the IMI-funded 
project eTRIKS https://www.etriks.org.  
 
A common and reasonable concern for patients is the risk of the misappropriation of their health 
information, particularly of genetic data (Fallik, 2014; Millier, 1998; Riba, 2007) that may adversely 
affect personal circumstances, including insurance coverage and employment. (Feldman et al., 2012). 
Data access and confidentiality risks are directly correlated (Kum & Ahalt, 2013). In specifically 
excluding personal medical data from general principles making public data open-by-default, the EC’s 
Open Data policy appears to reflect these concerns. The EC has planned to address patient 
confidentiality concerns through amendments to existing data protection directives (Directive 
95/46/EC; EU COM/2012/11. 2012) following EU constitutional revisions that strengthened personal 
data protection rights (Treaty of Lisbon, 2008).  
 
The Directive on patients' rights (Article 14) addresses legal policy cooperation on eHealth. The 
eHealth Network Multi-Annual Work Plan 2015-2018 defines concrete actions to be taken in the 
domains of interoperability and standardisation; exchange of knowledge; assessment of 
implementation; and global cooperation and positioning cross the European Union (Multi-Annual 
Work Plan 2015-2018). The adoption of guidelines on the electronic exchange of patient summaries, 
(November 2013) is one example of the development of electronic exchange to meet the requirements 
of the Cross-Border Directive (2011/21/EU. 2013: Brussels). These legislative changes unify EU 
initiatives on confidentiality and data security, provide a flexible legal framework that can rapidly 
adapt to changing technologies. Data protection reforms have arguably been few and limited to 
enhancing transparency and confidentiality in lawful data processing (Salas-Vega et al., 2015), but 
this is set to change as the GDPR comes into force in 2018 (Maldoff, 2016).  
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3.3 Standards & Interoperability 
There are still standardization problems in the healthcare sector, as data is often stored inconsistently, 
or stored in systems that produce and consume incompatible formats (Roney, 2012). Research, 
clinical activities, hospital services, education, and administrative services are siloed, and, in many 
organizations. Each silo maintains its own separate organizational (and sometimes duplicated) data 
and information infrastructure. The lack of coordination between systems, health care providers and 
countries, supports the call for standards to facilitate interoperability among the components of the big 
data value chains (EU Report - Use of Big Data in Public Health Policy Research, 2014). 
 
3.4 Technical Issues 
Robust scientific and data processing methodologies involve the validation of algorithms, filtering 
systems for noisy data, managing biases, and the selection of appropriate data streams. 
Methodological robustness is an ethical, not just a scientific requirement. Limited resources are 
wasted based on defective results and incomplete analyses, but also because trust in health care 
systems and professionals can be undermined by the use of misleading or inaccurate results (Vayena 
et al., 2015).  
 
4.0 Conclusions & Future Implications 
Health care delivery is a major challenge for all EU member states. The growth of big data in this 
sector, and the wider use of data analytics platforms offer a promise of more effective and efficient 
delivery of health care in the future. The MIDAS study is being undertaken to develop data 
forecasting, dashboards and visualisation technology to provide sustainable solutions in four 
European countries relating to diabetes, obesity, children in care and mental health services.               
Part of the work is a systematic approach to addressing the problems of governance, confidentiality, 
security as well as the complex technical issues involved in working with heterogeneous data sources. 
The aim is to support the development of new tools for health policy development and monitoring, 
and ultimately new policies for health service delivery. Unless these issues can be addressed in a way 
which meets the legitimate concerns of health service users, and the increasingly strict legal 
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